Featured APHA Stallion

Featured Auto For Sale

International Arabian Horse Association IAHA NSAIDS Drug Report
Our Charge: "Conduct an impartial study to determine which AHSA category best serves the Arabian Horse Breed -- No Foreign Substance or Therapeutic Substance Group"

Table of Contents


(See References Table)

IAHA Drugs/Medication ad hoc Study Committee
NOTE 1, Table I

NSAIDs, including phenylbutazone, ketoprofen, mectofemine acid, naproxen, and flunixin, predominately reduce pain by the reduction in tissue swelling.   (See References--No. 2)

All NSAIDs induce undesirable and potentially life-threatening side effects.  The majority of adverse reactions reflect the inhibitory effects of NSAIDs on prostaglandin activity.  In addition, acute intoxication by several drugs can be fatal.  The major toxicities associated with NSAIDS affect the GI, hematopoietic and renal systems.  (See References--No. 3)

Scientific literature and clinical veterinary experience support the proposition that multiple NSAIDs administered simultaneously, NSAIDS administered in large doses, and/or NSAIDs administered chronically possess a high potential of toxicity to the horse.  (See References--No. 4) Research studies have demonstrated that when ketafen is administered close to competition, or at higher doses, the result is to relieve pain from more extensive tissue damage.  (See References--No. 4)

“The presence of four or five NSAIDS in samples from the same horse competing at AHSA shows, and the high concentration of these drugs, constitutes “inhumane treatment.  The time to halt these abuses is long overdue,” stated Dr. George Maylin of New York, Professor at the Cornell University of College of Veterinary Medicine, veterinary pharmacologist, and consultant to the AHSA Drugs & Medications Committee. “We must get back to the original spirit of the Drugs & Medication Rule.  It has never been the AHSA’s intent to allow the use of painkillers in horses, and that is how ketoprofen and other NSAIDS are being used in many instances in the show ring.  AHSA shows and events are no place for lame horses to compete,” stated by Mr. Ed Bonnie, Chairman of the AHSA Drugs & Medication Committee.  (See References--No. 5)

It should be remembered, medications are developed and approved for specific uses at recommended dosages.  Continuous use without periodic evaluation of medical conditions can contribute to complications.  In many cases, further damage to the musculoskeletal system of the horse could be prevented with better diagnostics and medical/surgical management.  (See References--No. 6)

AWhiteHorse.net™ Community Logo

Website Design and Hosting
Stacey Mayer C. 2023